Bruce & Co portfolio · Q1 2026
Bruce & Co., Inc. · CIK 0001358331 ·13F filings on SEC EDGAR
In Q1 2026, Bruce & Co., Inc. reported 41 positions worth $349.7M. Its largest holding was 302571104 at 8.0% of the portfolio, and the top 10 made up 60%. Its largest new position was BBNX ($5.5M); it did not sell out of any holding.
- NEW 2
- ADD 2
- REDUCE 5
- EXIT 0
Portfolio map
Each box is a position sized by its value. Color shows the change in shares from the previous quarter. The smallest 1 positions are grouped as one box.
Portfolio history
Q4 2025 to Q1 2026, 2 quarters
Weight of the largest holdings
The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.
Holding timeline
Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.
Holdings
Click a holding to see its price chart with the quarters the investor bought or sold.
| Name | Weight | Avg. cost (est.) | Latest price | Gain/loss | Value |
|---|---|---|---|---|---|
302571104 Nextera Energy | 7.98% | $86.42* | $75.74 | -12.4% | $22.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ABBV ABBVIE INC | 7.62% | $88.64* | $261.59 | +195.1% | $32M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ALL ALLSTATE CORP | 7.33% | $73.67* | $221.86 | +201.1% | $27.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AER AERCAP HOLDINGS NV | 7.20% | $96.45 | $143.52 | +48.8% | $26.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
589331107 Merck | 6.63% | — | $145.31 | — | $28M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
UHAL.B U-HAUL HOLDING CO-NON VOTING | 5.77% | $55.44 | $52.85 | -4.7% | $23.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DUK DUKE ENERGY CORP | 5.46% | $80.86* | $114.01 | +41.0% | $16.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
T AT&T INC | 4.34% | $22.18 | $24.40 | +10.0% | $12.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
XEL XCEL ENERGY INC | 4.19% | $42.00* | $70.48 | +67.8% | $13M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CMS CMS ENERGY CORP | 3.46% | $42.65* | $63.08 | +47.9% | $9.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ABT ABBOTT LABORATORIES | 3.34% | $46.38* | $98.83 | +113.1% | $11.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
IIIN INSTEEL INDUSTRIES INC | 3.33% | $26.79 | $29.13 | +8.7% | $10M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
NEM NEWMONT CORP | 3.10% | $39.70 | $115.34 | +190.5% | $11.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VICR VICOR CORP | 2.99% | $43.74 | $288.94 | +560.5% | $18.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AAPL APPLE INC | 2.82% | $62.13 | $333.02 | +436.0% | $13M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BG BUNGE GLOBAL SA | 2.55% | $100.31 | $106.95 | +6.6% | $7.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AVA AVISTA CORP | 2.31% | $40.77* | $35.09 | -13.9% | $7.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PFE PFIZER INC | 2.18% | $31.17* | $28.52 | -8.5% | $7.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ADM ARCHER-DANIELS-MIDLAND CO | 2.08% | $61.28 | $79.38 | +29.5% | $7.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DAR DARLING INGREDIENTS INC | 1.87% | $47.28 | $60.71 | +28.4% | $6.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
KOD KODIAK SCIENCES INC | 1.58% | $6.20 | $94.80 | +1,429.0% | $13.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BBNX BETA BIONICS INC | 1.58% | $10.02 | $18.98 | +89.4% | $10.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CC CHEMOURS CO/THE | 1.58% | $13.11 | $13.57 | +3.5% | $3.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
868459108 SUPERNUS PHARMACEUTICALS | 1.48% | $32.34* | $43.04 | +33.1% | $4.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LYB LYONDELLBASELL INDU-CL A | 1.38% | $54.92 | $57.47 | +4.6% | $3.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
UHAL U-HAUL HOLDING CO | 1.01% | $340.53* | $60.17 | -82.3% | $4.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
RLI RLI CORP | 0.67% | $107.21* | $55.31 | -48.4% | $2.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LLY ELI LILLY & CO | 0.53% | $772.00 | $1,157.08 | +49.9% | $2.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
APOG APOGEE ENTERPRISES INC | 0.48% | $33.54 | $35.37 | +5.5% | $1.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
FOCL EDAP TMS SA -ADR | 0.47% | $4.02* | $4.47 | +11.2% | $2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VG VENTURE GLOBAL INC-CL A | 0.45% | $10.30 | $12.64 | +22.7% | $1.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PSNL PERSONALIS INC | 0.42% | $2.30 | $16.28 | +607.8% | $3.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
82968B103 SIRIUS XM HOLDINGS INC | 0.37% | $3.95* | $25.88 | +555.2% | $1.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
FATE FATE THERAPEUTICS INC | 0.27% | $3.07 | $2.37 | -22.8% | $1.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
044209104 Ashland | 0.24% | $109.96* | $67.92 | -38.2% | $1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VTRS VIATRIS INC | 0.23% | $13.52 | $17.72 | +31.1% | $1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
91911K102 Bausch Health | 0.19% | $18.86 | $5.83 | -69.1% | $722.9K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MNKD MANNKIND CORP | 0.14% | $3.84 | $3.90 | +1.6% | $760.8K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CRBU CARIBOU BIOSCIENCES INC | 0.14% | $3.73 | $1.27 | -66.0% | $317.5K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
WEC WEC ENERGY GROUP INC | 0.13% | $78.46 | $100.78 | +28.4% | $397.6K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MASS 908 DEVICES INC | 0.12% | $7.62 | $12.34 | +61.9% | $842.6K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Mar 31, 2016, when our collected history starts, so the average starts from that quarter's price.
Changes in shares
Change in shares held vs Dec 31, 2025, for the 9 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.
SEC filings for Q1 2026
- 13F-HR 0001104659-26-061024 · accepted May 14, 2026, 18:33 UTC